Journal Detail - WANFANG MED ONLINE

You Position: Home > Journal Detail

Journal of Clinical Hepatology

ISSN:: 1001-5256

CN:: 22-1108/R

Founded in:: 1985

Sponsor:: 中华人民共和国教育部

Indexed in:: EMBase ISTIC PKU OA

Email:: lcgdb@vip.163.com

Publication presents

《临床肝胆病杂志》于1985年创刊，是中华人民共和国教育部主管，吉林大学主办，中华医学会肝病学分会学术支持的医学专业期刊，是我国首个肝胆病专业杂志。ISSN 1001-5256，CN 22-1108/R。本刊为百种中国杰出学术期刊（2018年、2020年、2021年、2022年）、中国精品科技期刊暨“中国精品科技期刊顶尖学术论文（F5000）”项目来源期刊（2023-2026）、《科技期刊世界影响力指数（WJCI）报告》收录期刊（Q3区）、北大中文核心期刊、中国科技论文统计源期刊（中国科技核心期刊）、RCCSE中国核心学术期刊（A）。本刊核心影响因子为1.379，较18种消化病学类核心期刊核心影响因子平均值（0.891）高出96.7%；核心总被引频次为4253，较17种消化病学类核心期刊核心总被引频次平均值（1239）高出243.3%；综合评价总分为76.6，连续4年在消化病学类核心期刊排名第1位。本刊以提升肝胆胰疾病临床诊疗水平和推动基础研究向临床转化为方向，以服务广大临床医生和科研工作者为己任，主要反映国内外肝胆胰疾病防治工作的重大进展，促进国内外肝胆胰领域学术交流。刊载内容实行肝胆胰并重，内外科并重，中西医并重，临床与基础并重。设述评、专家论坛、热点·视点·观点、学术争鸣、指南与规范、指南解读、论著、临床病例讨论、临床经验交流、病例报告、综述、国内外会议动态、国外期刊精品文章简介等栏目。本刊由中国工程院庄辉院士担任名誉主编，由中华医学会肝病学分会名誉主任委员，亚太地区肝病学会、国际肝病学会前主席贾继东教授和原吉林大学第一医院副院长、中华医学会肝病学分会肝癌学组组长、吉林省传染病学会名誉主任委员和肝脏病学会主任委员牛俊奇教授担任主编。编委会由国际国内347名具有丰富诊疗经验，高学术造诣的专家和学科带头人组成，其中院士编委14人、外籍及港澳台编委21人。目前拥有千余名学科齐全、学术造诣深厚的审稿专家，来稿一律实行同行评议。本刊为月刊，全年12期，16开本，每月25日发行，2024年每期定价60元。杂志国内外公开发行。邮局订购邮发代号12-80。

Latest updates

1: Value of alkaline phosphatase level after ursodeoxycholic acid treatment for one month and baseline red blood cell distribution width in predicting the treatment response of primary biliary cholangitis (王楠胡蓉卞石惠仲威张鹏飞谭友文)
2: Efficacy and safety of cryoablation combined with lenvatinib and anti-PD-1 monoclonal antibody in treatment of unresectable hepatocellular carcinoma (刘腾常秀娟何权威徐然杨永平)
3: Diagnosis and treatment principles of liver injury induced by antithyroid drugs (杨睿涛杨锐邓勋曾森祥杨晓燕)
4: Establishment of a nomogram model for predicting liver cirrhosis with esophagogastric variceal bleeding based on aspartate aminotransferase-to-platelet ratio index and platelet-albumin-bilirubin score (李欣忆李娇娇李莹莹魏虹合熊雨凡张新驰孙蔚陈丽)
5: Key points of the international Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas(2023) (李家速孙洪鑫李兆申)
6: Influencing factors for death within 30 days in patients with decompensated hepatitis B cirrhosis and hepatic encephalopathy (黄云义时克王宪波)
7: Epidemiology and clinical outcome of chronic hepatitis B virus infection and metabolic dysfunction (黄娇凤郑琦)
8: Influencing factors for the prognosis of patients with drug-induced liver injury and establishment of a nomogram model (王诗美靳帅李俊儒王娜陈岩崔莹马明明胡晓丽)
9: Application of Mendelian randomization analysis in exploring the etiology of nonalcoholic fatty liver disease (郭紫薇武庆娟叶永安陈兰羽吕文良)
10: Application of endocrine indices and ultrasound examination in the early diagnosis of pediatric pancreatic injury (金明均孙溶涓董亮詹江华)
11: Re-understanding of the mechanism of coagulation disorder in liver cirrhosis (孙荣荣贺娜张粉娜张心怡王梓依王辉边娜娜闫红林)
12: Erythropoietic protoporphyria with liver cirrhosis as the main manifestation:A case report (吴振东周国强向燕王先令苏剑东刘思纯)
13: Efficacy and safety of transcatheter arterial chemoembolization combined with targeted therapy and immunotherapy in treatment of patients with stage Ⅱb/Ⅲa hepatocellular carcinoma based on China Liver Cancer Staging (胡泽鑫李佳清李婉慈仲斌演张帅沈健朱晓黎)
14: Efficacy of ursodeoxycholic acid in the prevention and treatment of COVID-19 in patients with chronic hepatitis B (崔心宇李彦彦朱娜林颖莹李鑫)
15: Current reviewers (No author available)
16: Application value of two-dimensional shear wave elastography and serological models in the staging of liver fibrosis in patients with chronic hepatitis B (黄玉洁冯斯奕)
17: Expert consensus on the molecular diagnosis of early-stage pancreatic cancer(2023 edition) (中国医师协会临床精准医疗专业委员会中国抗癌协会肿瘤胰腺病学专业委员会肖桂山郭俊超郭晓钟)
18: Role of mesenchymal stem cells and their exosomes in the treatment of drug-induced liver injury (邢国静罗龙龙王丽菲王顺娜郑晓凤卢利霞张久聪)
19: Application of magnetic resonance imaging-proton density fat fraction in liver fat quantification (杨晨余上海徐飞鹏张华)
20: Role and mechanism of action of Yinchenhao Decoction in inhibiting ferroptosis of hepatocytes in mice with autoimmune hepatitis (李竹蓉陈晨郭地吕思学武嘉文杨娜刘杨)
21: Effect of human umbilical cord mesenchymal stem cells in treatment of mice with liver fibrosis and its mechanism (刘平箕姚黎超胡雪王铮熊芷玉江应安)
22: Development and validation of a prognostic model for 90-day survival in patients with alcohol-associated cirrhosis and acute decompensation (全卉于浩江宇泳)
23: Chronic hepatitis B virus infection and metabolic associated fatty liver disease:The known and unknown aspects (耿楠倪文婧芮法娟李婕)
24: 《临床肝胆病杂志》2024年1～11期重点号选题及执行主编 (《临床肝胆病杂志》编辑部)
25: Current status of research on the genetic susceptibility of primary biliary cholangitis (赵春梅马狄邰文琳)
26: Association between the risk of increase in total cholesterol and the risk of cholelithiasis:A bidirectional Mendelian randomization study (赵伟伟杜晓旭戈宏焱)
27: Guidelines for traditional Chinese medicine diagnosis and treatment of liver cirrhosis (中华中医药学会肝胆病分会王宪波高方媛刘尧李秀惠赵文霞朱英)
28: ABCB4 gene mutation-associated liver cirrhosis with gallstones:A case report (刘文迪王芃胡和平周华邦)
29: 更正 (No author available)
30: Basic research on chronic hepatitis B virus infection and metabolic dysfunction:Advances and controversies (余博容陈源文)
31: 《临床肝胆病杂志》关于不法人员冒用本刊名义实施邮件诈骗的严正声明 (《临床肝胆病杂志》编辑部)
32: Capsaicin receptor TRPV1 maintains quiescence of hepatic stellate cells in the liver via recruitment of SARM1 (陶乐杨广越 SUN T)
33: Role of podoplanin in hepatic stellate cell activation and liver fibrosis (王知意杨广越张玮浦娅琼赵鑫马文婷刘旭凌吴柳陶乐刘成)
34: Research advances in neutrophil extracellular traps and liver diseases (仁增卓嘎杨康洁芦永良王志鑫王海久)
35: Regulatory effect and mechanism of macrophage polarization in liver fibrosis (白小洋张旭海龙丁向春)
36: Significance of high-sensitivity polymerase chain reaction in detecting hepatitis B virus in chronic hepatitis B patients with a very low viral load (邱功钦谢丹陈姿任欧阳石)
37: 《临床肝胆病杂志》关于伦理审查的要求 (No author available)
38: Clinical management of chronic hepatitis B virus infection comorbid with metabolic dysfunction (羊璐萍施军平)
39: Clinical significance of determining the level of biliary calprotectin in patients with cholangiocarcinoma or choledocholithiasis (计婷婷白冰清崔喻芳汪少飞洪江龙李扬鲍峻峻梅俏)
40: Mechanism of action of Polygonum multiflorum in inducing liver injury:A study based on signaling pathways (梁子晗李佳辉程爽袁卓雅荣文雅刘亚杰郝玉洁王睿林)
41: Role of Akkermansia muciniphila in nonalcoholic fatty liver disease (郑立婷汪哲陈玉春刘珊山解有成李初谊于晓辉)
42: 《临床肝胆病杂志》推荐使用的规范医学名词术语 (No author available)
43: 《临床肝胆病杂志》综合评价总分在消化病学类核心期刊中连续5年排名第一 (《临床肝胆病杂志》编辑部)
44: Clinical efficacy of double plasma molecular absorption system and sequential plasma exchange combined with continuous renal replacement therapy in treatment of acute-on-chronic liver failure with acute kidney injury (文苑祝娟娟)

All Issues

2024:

2023:

2022:

2021:

2020:

2019:

2018:

2017:

2016:

2015:

2014:

2013:

2012:

2011:

2010:

2009:

2008:

2007:

2006:

2005:

2004:

2003:

2002:

2001:

2000:

1999:

1998:

Journal of Clinical Hepatology